Skip to content

Envista Holdings

US · NVST #2329 by market cap Listed 2019
22.91 -0.36 -1.55%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 21 in the most recent period (2026/Q3).
  • Total institutional ownership rose 8.7 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
127.68% +8.75pp
Institutions
474 +21
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund99.79%
Hedge Fund17.14%
Public Company6.21%
Government Pension Fund1.55%
Sovereign Wealth Fund1.37%
Private Company0.76%
Insurance Company0.43%
Individual/Insider0.42%
Family Office/Trust0.33%

Top holders as of 2026-09-30

BlackRock 11.78% · 18.89M sh
Ariel Investments, LLC 6.12% · 9.82M sh
Dimensional Fund Advisors 6.08% · 9.74M sh
Vanguard Portfolio Management, LLC 4.63% · 7.42M sh
Vanguard Capital Management, LLC 4.44% · 7.12M sh
Morgan Stanley 4.16% · 6.67M sh
Morgan Stanley Investment Management Inc. 4.16% · 6.67M sh
Eaton Vance Management 3.71% · 5.95M sh
State Street Global Advisors 3.32% · 5.33M sh
AllianceBernstein 3.25% · 5.21M sh
Gates Capital Management, Inc. 3.46% · 5.55M sh
American Century Investment Management 3.31% · 5.31M sh
Arrowstreet Capital, Limited Partnership 3.02% · 4.85M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 31 buys · 15 sells

NameRoleStake
Paul Keel Chairperson & CEO 0.13%
Amir Aghdaei Former Chief Executive Officer 0.09%
Barbara Hulit Former Independent Director 0.04%
Mark Nance Senior Vice President 0.04%
Eric Hammes Senior Vice President 0.03%
Stefan Nilsson President of Nobel Biocare 0.02%
Faez Kaabi Former VP, Chief Accounting Officer & Corporate Controller 0.02%
Robert Befidi Senior VP & President of Diagnostics 0.02%
Mischa Reis Senior Vice President of Strategy & Corporate Development 0.02%
Veronica Acurio Senior VP & President of Orthodontics 0.01%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-10-31 Paul Keel Chairperson & CEO Sale to Issuer -54,197 $23.51
2026-08-24 Robert Befidi Senior VP & President of Diagnostics Sale to Issuer -5,147 $27.47
2026-08-24 Eric Hammes Senior Vice President Sale to Issuer -10,885 $27.47
2026-08-24 Veronica Acurio Senior VP & President of Orthodontics Sale to Issuer -7,710 $27.47
2026-08-24 Stefan Nilsson President of Nobel Biocare Sale to Issuer -804 $27.47
2026-08-19 Mischa Reis Senior Vice President of Strategy & Corporate Development Automatic Disposition -8,000 $27.50
2026-08-17 Paul Keel Chairperson & CEO Other Acquisition +179,730 --
2026-08-17 Paul Keel Chairperson & CEO Other Derivative Acquisition +159,900 --
2026-08-17 Eric Hammes Senior Vice President Other Derivative Acquisition +47,970 --
2026-08-05 Coree Thomas Vice President Initial Statement of Beneficial 0 --
2026-05-24 Paul Keel Chairperson & CEO Sale to Issuer -12,811 $23.43
2026-05-18 Daniel Raskas Independent Director Other Acquisition +9,330 --
2026-05-18 Christine Tsingos Independent Director Other Acquisition +9,330 --
2026-05-18 Kieran Gallahue Independent Director Other Acquisition +9,330 --
2026-05-18 Richard Huennekens Lead Independent Director Other Acquisition +12,585 --
2026-05-18 Vivek Jain Independent Director Other Acquisition +9,330 --
2026-05-18 Wendy Carruthers Independent Director Other Acquisition +9,330 --
2026-05-18 J. Pierce Independent Director Other Acquisition +9,330 --
2026-02-24 Paul Keel Chairperson & CEO Sale to Issuer -11,840 $29.59
2026-02-24 Paul Keel Chairperson & CEO Other Acquisition +48,670 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:02:33 · For reference only, not investment advice and not tailored to your situation.

Envista Holdings discussion 0 comments

Add a comment